Last Updated on October 15, 2024 by The Health Master
New Delhi: Zydus Lifesciences said it has received the USFDA’s final nod to market its generic version of Mirabegron extended-release tablets used to treat overactive bladder, with 180 days of shared generic drug exclusivity.
The final approval granted by the US Food and Drug Administration (USFDA) to the company’s US arm, Zydus Pharmaceuticals, Inc., is for the tablets of strengths of 25 mg and 50 mg, it said in a regulatory filing.
Zydus was one of the first applicants to submit a substantially complete ANDA (abbreviated new drugs application) with a paragraph IV certification for Mirabegron extended-release tablets, 25 mg, and 50 mg, and is, therefore, eligible for 180 days of shared generic drug exclusivity for the drug, it added.
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and urinary frequency.
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, the filing added.
As per IQVIA MAT August 2022 data, Zydus said Mirabegron extended-release tablets 25mg and 50mg had annual sales of USD 2.42 billion in the US.
USFDA gives approval for Sildenafil for oral suspension
USFDA approved this drug to prevent nerve cells dying prematurely
USFDA approves Mirabegron extended-release tablets
USFDA gives nod for this generic non-steroidal anti-inflammatory drug
USFDA approves Intravenous therapy for hearing loss
USFDA approves Terlipressin for injection to treat Kidney function
IPC launches 1000th IP Reference Standard
NDPS: Inter-state Pharmaceutical drug racket busted
USFDA issues 2 observations on Form 483 to Zydus Lifesciences
DCGI panel recommends ban on these Fixed dose combination drugs
Bar codes could come soon to stop the threat of sub-standard drugs
Govt notifies RDTL Chandigarh as Central Medical Devices Testing Laboratory
Drug recall: Acyclovir Sodium Injection recalled due to this reason
Changing the Regulations for Class A Medical Devices and its Impact
Govt plan to ban Codeine based cough syrups opposed by Pharma companies
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
